Used in pharmaceutical synthesis, particularly in the development of boron-containing drugs. Its boronic acid-like structure enables participation in Suzuki-Miyaura cross-coupling reactions, making it valuable in creating biaryl compounds for medicinal chemistry. It serves as an intermediate in synthesizing protease inhibitors and other bioactive molecules, especially in treatments targeting viral infections and cancers. The compound’s ability to form reversible covalent bonds with biological targets enhances its utility in designing enzyme inhibitors with high selectivity and potency.